Q BioMed Inc.
Q BioMed Inc.
Insider Sentiment (TTM):
Last Purchase:-Last Sale:2018-07-12Shares Purchased (TTM):0Shares Sold (TTM):0
Institutional Sentiment:
As of:2021-06-30Institutional Shares Owned:10,615Shares Outstanding:26,283,700Institutional Ownership Pct.:0.04%
Earnings Market Reaction:
Filing Date:2023-06-23Price on Filing Date:N/APrevious Close:N/A% Change:N/A
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2023-02-28 | 2022-11-30 | 2022-08-31 | 2022-05-31 | 2022-02-28 | 2021-11-30 | 2021-08-31 | 2021-05-31 | 2021-02-28 | 2020-11-30 | 2020-08-31 | 2020-05-31 | 2020-02-29 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Convertible Series Preferred Stock | 0 | 1 | 0 | 0 | 0 | 1 | -0 | 0 | 1 | 0 | 0 | 1 | - | |||||
Convertible Series B Preferred Stock | 0 | 1 | -0 | -0 | 0 | 1 | -1 | 0 | 1 | 1 | 0 | 1 | - | |||||
Convertible Series C Preferred Stock | 100 | 100 | - | - | - | 100 | - | - | - | - | - | - | - | |||||
Assets | ||||||||||||||||||
Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 1 | |||||
Assets Current | ||||||||||||||||||
Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 1 | |||||
Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 | 0 | - | |||||
Inventory Net | - | - | 0 | 0 | - | 0 | - | - | - | - | - | - | - | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Long Term Investments | 3 | 3 | - | - | - | - | - | - | - | - | - | - | - | |||||
Finite Lived Intangible Assets Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 3 | 4 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 1 | |||||
Liabilities And Stockhold… | ||||||||||||||||||
Accounts Payable Current | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | |||||
Convertible Notes Payable Current | - | - | - | - | - | 3 | 1 | 1 | 1 | 0 | 0 | 0 | 2 | |||||
Accrued Liabilities Current | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Accounts Payable Related Parties Current | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | ||||||||||||||||||
Interest Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | 10 | 8 | 8 | 8 | 6 | 5 | 4 | 3 | 3 | 2 | 2 | 2 | 4 | |||||
Notes Payable Related Parties Classified Current | - | - | - | - | - | - | - | 0 | - | - | - | - | - | |||||
Debt Current | 4 | 4 | 4 | 3 | 3 | 3 | - | - | - | - | - | - | - | |||||
Derivative Liabilities Current | 0 | 0 | 0 | 1 | - | - | - | - | - | - | - | - | - | |||||
Long Term Debt | ||||||||||||||||||
Convertible Notes Payable | - | - | - | - | - | - | - | - | - | - | - | - | 2 | |||||
Long Term Debt | - | - | - | - | - | - | - | - | - | - | 0 | - | 2 | |||||
Liabilities | 10 | 8 | 8 | 8 | 6 | 5 | 4 | 3 | 3 | 2 | 2 | 2 | 6 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | ||||||||||||||||||
Stockholders Equity | -6 | -5 | -7 | -7 | -6 | -5 | -3 | -2 | -2 | -1 | 0 | 2 | -5 | |||||
Additional Paid In Capital | 57 | 56 | 56 | 55 | 54 | 53 | 53 | 52 | 50 | 48 | 45 | 45 | 43 | |||||
Retained Earnings Accumulated Deficit | -68 | -66 | -68 | -68 | -66 | -64 | -62 | -60 | -58 | -56 | -52 | -50 | -48 | |||||
Liabilities And Stockholders Equity | 3 | 4 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 1 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |||||
Preferred Stock Shares Issued | - | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Preferred Stock Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | |||||
Common Stock Shares Issued | 133 | 84 | 57 | 39 | 31 | 29 | 28 | 27 | 26 | 24 | 23 | 23 | 21 | |||||
Shares Outstanding | 133 | 84 | 57 | 39 | 31 | 29 | 28 | 27 | 26 | 24 | 23 | 23 | 21 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
0/5
Search a metric to start building a table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
0/1
Search a metric to start building a visual
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 1185.71% | 342.86% | -71.43% | - | - | - | - | - | - | - | - | - |
| 2022 | -32.63% | -55.52% | -79.14% | -83.04% | -86.55% | -91.81% | -47.08% | -45.83% | -62.50% | -25.47% | -15.09% | -70.75% |
| 2021 | -5.00% | -3.57% | -9.95% | -10.46% | -11.49% | -14.37% | -15.00% | -26.23% | -28.31% | -8.64% | -45.50% | -67.94% |
| 2020 | - | - | - | 2.41% | -30.12% | -25.60% | -8.70% | -10.43% | -15.65% | -4.76% | -9.52% | -7.14% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2023-02-28 | 2022-11-30 | 2022-08-31 | 2022-05-31 | 2022-02-28 | 2021-11-30 | 2021-08-31 | 2021-05-31 | 2021-02-28 | 2020-11-30 | 2020-08-31 | 2020-05-31 | 2020-02-29 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | ||||||||||||||||||
| Current Ratio | 0.00 | 0.01 | 0.02 | 0.02 | 0.03 | 0.08 | 0.07 | 0.14 | 0.18 | 0.13 | 0.88 | 2.11 | 0.19 | |||||
| Quick Ratio | 0.00 | 0.01 | 0.02 | 0.01 | 0.03 | 0.08 | 0.05 | 0.11 | 0.16 | 0.10 | 0.80 | 2.00 | 0.18 | |||||
| Working Capital | -9.87M | -8.06M | -7.55M | -7.42M | -6.17M | -5.04M | -3.36M | -2.57M | -2.17M | -1.48M | -195.80K | 1.69M | -3.31M | |||||
Leverage & Debt | ||||||||||||||||||
| Debt to Equity | -1.54 | -1.76 | -1.07 | -1.07 | -1.09 | -1.17 | -1.20 | -1.36 | -1.48 | -1.58 | 13.89 | 0.72 | -1.24 | |||||
| Interest Coverage TTM | -0.55 | -1.01 | -3.56 | -4.41 | -7.43 | -15.26 | -42.09 | -72.38 | -72.13 | -47.45 | -19.62 | -10.85 | -9.13 | |||||
| Debt Ratio | 2.86 | 2.31 | 15.53 | 16.08 | 11.83 | 6.79 | 5.98 | 3.79 | 3.07 | 2.72 | 0.93 | 0.42 | 5.23 | |||||
Efficiency & Turnover | ||||||||||||||||||
| Asset Turnover TTM | 0.10 | 0.13 | 0.69 | 0.63 | 0.39 | 0.27 | 0.07 | 0.03 | 0.03 | 0.05 | 0.02 | 0.01 | 0.00 | |||||
| Days Sales Outstanding TTM | - | 58.81 | 24.42 | 53.31 | 37.37 | 149.47 | 103.00 | 160.90 | - | - | 149.65 | 279.83 | - | |||||
| Receivables Turnover TTM | - | 6.21 | 14.95 | 6.85 | 9.77 | 2.44 | 3.54 | 2.27 | - | - | 2.44 | 1.30 | - | |||||
Per Share Metrics | ||||||||||||||||||
| Diluted EPS TTM | -0.02 | -0.08 | -0.16 | -0.22 | -0.27 | -0.31 | -0.37 | -0.42 | -0.44 | -0.65 | -0.57 | - | - | |||||
| Free Cash Flow Per Share TTM | 0.02 | 0.04 | -0.05 | -0.09 | -0.13 | -0.16 | -0.15 | -0.19 | -0.23 | -0.28 | -0.26 | -0.20 | -0.19 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | ||||||||||||||||||
| Gross Profit Margin TTM | -6.02% | -3.16% | 20.58% | 22.62% | -3.53% | -26.20% | -223.75% | -530.51% | -1,122.01% | - | - | - | - | |||||
| Operating Profit Margin TTM | -1,032.32% | -1,012.84% | -1,195.07% | -1,343.74% | -2,291.35% | -3,777.44% | -10,137.05% | -16,397.78% | -32,213.09% | -43,818.05% | -45,725.79% | -88,159.23% | - | |||||
| Net Profit Margin TTM | -920.75% | -1,228.79% | -1,857.77% | -1,872.23% | -2,975.80% | -4,213.02% | -11,373.08% | -18,215.39% | -36,277.94% | -47,834.05% | -42,260.55% | -85,471.77% | - | |||||
Growth Metrics | ||||||||||||||||||
| Net Revenue Growth (1Y) | -22.67% | 45.38% | 315.48% | 560.24% | 802.19% | 551.99% | 202.25% | 300.00% | - | - | - | - | - | |||||
| Net Income Growth (1Y) | -76.07% | -57.60% | -32.13% | -32.14% | -26.00% | -42.58% | -18.66% | -14.75% | -21.40% | 39.60% | 27.96% | 23.91% | 46.19% | |||||
| EPS Growth (1Y) | -93.49% | -74.63% | -58.19% | -45.96% | -38.37% | -52.48% | -34.03% | -26.54% | -32.04% | 50.03% | -13.40% | -19.71% | -0.75% | |||||
Calculated Values | ||||||||||||||||||
| Free Cash Flow TTM | 2.18M | 1.94M | -2.29M | -2.89M | -3.86M | -4.30M | -4.21M | -5.07M | -5.65M | -6.23M | -5.79M | -4.59M | -4.13M | |||||
| Net Debt | 4.03M | 4.06M | 3.63M | 3.39M | 3.21M | 2.71M | 1.04M | 679.14K | 454.05K | -84.96K | -1.24M | -2.92M | 3.87M | |||||
Per-Share and Margin | ||||||||||||||||||
| EPS TTM | ||||||||||||||||||
| Adjusted EPS TTM | ||||||||||||||||||
| Cash Flow Per Share TTM | ||||||||||||||||||
| Pretax Margin TTM | ||||||||||||||||||
| Stock Comp to Revenue TTM | ||||||||||||||||||
Turnover Ratios and Averages | ||||||||||||||||||
| Average Assets | ||||||||||||||||||
| Average Equity | ||||||||||||||||||
| Average Inventory | ||||||||||||||||||
| Average Receivables | ||||||||||||||||||
| Average Accounts Payables | ||||||||||||||||||
| Inventory Turnover TTM | ||||||||||||||||||
| Payables Turnover TTM | ||||||||||||||||||
| Days Inventory Outstanding TTM | ||||||||||||||||||
| Days Payables Outstanding TTM | ||||||||||||||||||
| Cash Conversion Cycle TTM | ||||||||||||||||||
| Working Capital to Revenue | ||||||||||||||||||
| Deferred Revenue to Revenue | ||||||||||||||||||
Growth Rates | ||||||||||||||||||
| Total Assets Growth (1Y) | ||||||||||||||||||
| Total Assets Growth (3Y) | ||||||||||||||||||
| Total Assets Growth (5Y) | ||||||||||||||||||
| Dividends Paid Growth (1Y) | ||||||||||||||||||
| Dividends Paid Growth (3Y) | ||||||||||||||||||
| Dividends Paid Growth (5Y) | ||||||||||||||||||
| EPS Growth (3Y) | ||||||||||||||||||
| EPS Growth (5Y) | ||||||||||||||||||
| Net Income Growth (3Y) | ||||||||||||||||||
| Net Income Growth (5Y) | ||||||||||||||||||
| Net Profit Margin Growth (1Y) | ||||||||||||||||||
| Net Profit Margin Growth (3Y) | ||||||||||||||||||
| Net Profit Margin Growth (5Y) | ||||||||||||||||||
| Net Revenue Growth (3Y) | ||||||||||||||||||
| Net Revenue Growth (5Y) | ||||||||||||||||||
| Deferred Revenue Growth (1Y) | ||||||||||||||||||
| Retained Earnings Growth (1Y) | ||||||||||||||||||
Credit, Liquidity, Returns, Payout | ||||||||||||||||||
| Cash Ratio | ||||||||||||||||||
| Net Working Capital | ||||||||||||||||||
| Debt to EBITDA TTM | ||||||||||||||||||
| Net Debt to EBITDA TTM | ||||||||||||||||||
| Net Debt to Equity | ||||||||||||||||||
| Altman A | ||||||||||||||||||
| Altman B | ||||||||||||||||||
| Altman C | ||||||||||||||||||
| Altman D | ||||||||||||||||||
| Altman E | ||||||||||||||||||
| Altman Z-Score | ||||||||||||||||||
| ROA TTM | ||||||||||||||||||
| ROE TTM | ||||||||||||||||||
| NOPAT TTM | ||||||||||||||||||
| ROIC TTM | ||||||||||||||||||
| Effective Tax Rate TTM | ||||||||||||||||||
| Payout Ratio TTM | ||||||||||||||||||
| Dilution Ratio | ||||||||||||||||||
| Retained Earnings to Equity | ||||||||||||||||||
| Treasury Stock to Equity | ||||||||||||||||||
| Treasury Stock Change (1Y) | ||||||||||||||||||
| Accrued to Current Liabilities | ||||||||||||||||||
| NCAV | ||||||||||||||||||
| NCAV Per Share TTM | ||||||||||||||||||
Valuation Ratios | ||||||||||||||||||
| P/CF TTM | ||||||||||||||||||
| PEG Ratio | ||||||||||||||||||
| Dividend Yield TTM | ||||||||||||||||||
| Free Cash Flow Yield TTM | ||||||||||||||||||
| EV EBITDA TTM | ||||||||||||||||||
| EV EBIT TTM | ||||||||||||||||||
| EV Revenue TTM | ||||||||||||||||||
| EV FCF TTM | ||||||||||||||||||
| Stock Compensation TTM | ||||||||||||||||||
| Adjusted Net Income TTM | ||||||||||||||||||
| Billings TTM | ||||||||||||||||||
| Total Debt | ||||||||||||||||||
| Invested Capital | ||||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
2018-07-12Sale
Owner: Corin, Denis
Title: Chief Executive Officer
Shares: 6,400
Price/Share: $2.11
Value: $13,504.00
Shares Owned: 2,435,400
Relationship: Director,Officer,TenPercentOwner
Ownership: Direct
2018-07-10Sale
Owner: Corin, Denis
Title: Chief Executive Officer
Shares: 7,000
Price/Share: $2.85
Value: $19,950.00
Shares Owned: 2,441,800
Relationship: Director,Officer,TenPercentOwner
Ownership: Direct
2018-07-06Sale
Owner: Corin, Denis
Title: Chief Executive Officer
Shares: 6,900
Price/Share: $3.58
Value: $24,702.00
Shares Owned: 2,455,800
Relationship: Director,Officer,TenPercentOwner
Ownership: Direct
2018-07-03Sale
Owner: Corin, Denis
Title: Chief Executive Officer
Shares: 2,200
Price/Share: $3.46
Value: $7,612.00
Shares Owned: 2,469,300
Relationship: Director,Officer,TenPercentOwner
Ownership: Direct
2018-06-29Sale
Owner: Corin, Denis
Title: Chief Executive Officer
Shares: 2,100
Price/Share: $3.40
Value: $7,140.00
Shares Owned: 2,473,500
Relationship: Director,Officer,TenPercentOwner
Ownership: Direct
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
No data available for chart
2021-06-30
0.04%
Inst. Shares: 10,615
Shares Outstanding: 26,283,700
2021-03-31
0.04%
Inst. Shares: 10,615
Shares Outstanding: 24,644,761
2020-12-31
0.05%
Inst. Shares: 10,615
Shares Outstanding: 22,160,426
2020-09-30
0.05%
Inst. Shares: 10,615
Shares Outstanding: 22,433,141
2020-06-30
0.05%
Inst. Shares: 10,615
Shares Outstanding: 22,433,141
Q BioMed Inc. (QBIO) — SEC Financial Statements & Analysis
Q BioMed Inc. (QBIO) is a pharmaceutical preparations company, incorporated in NV. Q BioMed Inc. trades on OTC as: QBIO. Based on its latest SEC filing (Form 10-Q, period ending 2023-02-28), Q BioMed Inc. reported a -22.67% year-over-year revenue growth, a Gross Profit Margin of -6.02% (TTM), a Debt-to-Equity ratio of -1.54x. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -22.67%
- Gross Profit Margin TTM
- -6.02%
- Debt To Equity
- -1.54x
Data as of 2023-02-28 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Q BioMed Inc. in?
Q BioMed Inc. (QBIO) operates in the Pharmaceutical Preparations industry.
What exchange does QBIO trade on?
Q BioMed Inc. (QBIO) trades on the OTC.
Where is Q BioMed Inc. incorporated?
Q BioMed Inc. is incorporated in NV.